Review of cost-based drug pricing framework recommended by Parliamentary Panel

A Parliamentary Committee has reportedly recommended examining the feasibility of reintroducing a cost-based pricing mechanism for medicines through statutory amendments where significant price disparities or excessive mark-ups are observed. The recommendation seeks to address pricing distortions that may not be captured under the existing market-based pricing framework.